Moleculent
Solna
About Moleculent
Moleculent is on a mission to develop technology-enabled products that leverage new insights into the molecular foundation of human biology. Developing amazing products to advance human health gives you purpose. they believe that our understanding of the molecular basis of human biology, in health and disease will increase radically in the coming ten years. This will lead to a vast improvement in therapies, diagnostics, and a new, fundamental understanding
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $26.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2024)
- Website: moleculent.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/moleculent-36833 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.